InsidersTradesSigma
Explore the detailed record of transactions filed by Johan Edewaard, Chairman & CEO. Director active across 2 companies, notably ODI Pharma AB (publ). Cumulatively, 1 disclosures have been recorded. The latest transaction was disclosed on 8 January 2026 — Purchase. Regulator: FIN-FSA. The full history is openly available.
1 of 1 declaration
Johan Edewaard is the Chairman & CEO of ODI Pharma AB (publ) and a member of its board. He is responsible for the strategic direction of the company and the management of its operations. His role is crucial for the success and growth of ODI Pharma.